Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Loss of Nmp4 enhances bone gain from sclerostin antibody administration

Bone(2023)10.1016/j.bone.2023.116891Source: DataRank Database

Loss of Nmp4 enhances bone gain from sclerostin antibody administration is a research paper published in Bone (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 0.69)OA: greenTopics (49)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Michele Adaway,Emily G. Atkinson ORCID,Daniel J. Horan,Angela J. Klunk ORCID,Brandy Suarez Silva

Live enrichment

PubMed:37660938 PMC:PMC10591883 OpenAlex:https://openalex.org/W4386400490

National Institutes of Health

Grant: 1R01 AR073739

National Institutes of Health

Grant: R01 AR053237

National Institutes of Health

Grant: T32 AR065971

National Institutes of Health

Grant: R21 AG078861

National Institutes of Health

Grant: VA 1I0 1BX005154

National Institutes of Health

Grant: I01 BX005861

National Institutes of Health

Grant: IK6 BX 003783

BLRD VA

Grant: I01 BX005154

NIAMS NIH HHS

Grant: R01 AR073739

US Department of Veterans Affairs

FWCI

0.69

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://scholarworks.indianapolis.iu.edu/bitstreams/122436db-b53f-4252-9a4a-93d29cdf1193/download

publisherhttps://api.elsevier.com/content/article/PII:S8756328223002247?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S8756328223002247?httpAccept=text/plain

repositoryhttps://hdl.handle.net/1805/45378

Fields of Study

Bone health and treatmentsBone Metabolism and DiseasesTGF-β signaling in diseasesAnimalsFemaleMiceAdaptor Proteins, Signal TransducingAntibodies, MonoclonalBone and BonesBone DensityMesenchymal Stem CellsMice, Inbred C57BLMice, KnockoutNuclear Matrix-Associated ProteinsOsteogenesisTranscription FactorsX-Ray Microtomography

MeSH Terms

AnimalsAntibodies, MonoclonalBone and BonesFemaleMice, Inbred C57BLOsteogenesisTranscription FactorsBone DensityMice, KnockoutNuclear Matrix-Associated ProteinsAdaptor Proteins, Signal TransducingMiceX-Ray MicrotomographyMesenchymal Stem Cells

Keywords

SclerostinEndocrinologyInternal medicineParathyroid hormoneTeriparatideOsteoblastBone mineralOsteocalcinOsteoporosisChemistryMedicineWnt signaling pathwaySignal transductionCalciumAlkaline phosphataseBone AnabolismOsteoanabolicsRomosozumab-aqqg

Sustainable Development Goals

SDG 0: Good health and well-being